Cargando…

VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients

CD34(+)/CD133(+)- cells are a bone marrow derived stem cell population, which presumably contain vascular progenitor cells and are associated with improved vascular repair. In this study, we investigated whether the adhesion molecules ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular adhe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patry, Christian, Remmé, Christoph, Betzen, Christian, Tönshoff, Burkhard, Yard, Benito A., Beck, Grietje, Rafat, Neysan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877884/ https://www.ncbi.nlm.nih.gov/pubmed/29601599 http://dx.doi.org/10.1371/journal.pone.0195064

Ejemplares similares

CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients
por: Patry, Christian, et al.
Publicado: (2018)

Bone marrow-derived progenitor cells attenuate inflammation in lipopolysaccharide-induced acute respiratory distress syndrome
por: Rafat, Neysan, et al.
Publicado: (2014)

Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis
por: Krebs, Jörg, et al.
Publicado: (2019)

Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation
por: Patry, Christian, et al.
Publicado: (2020)

Corrigendum: Endothelial Progenitor and Mesenchymal Stromal Cells in Newborns With Congenital Diaphragmatic Hernia Undergoing Extracorporeal Membrane Oxygenation
por: Rafat, Neysan, et al.
Publicado: (2020)

Endothelial Progenitor and Mesenchymal Stromal Cells in Newborns With Congenital Diaphragmatic Hernia Undergoing Extracorporeal Membrane Oxygenation
por: Rafat, Neysan, et al.
Publicado: (2019)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Cross-sectional analysis on publication status and age representation of clinical studies addressing mechanical ventilation and ventilator-induced lung injury in infants and children
por: Patry, Christian, et al.
Publicado: (2018)

High mobilization of CD133+/CD34+ cells expressing HIF-1α and SDF-1α in septic abdominal surgical patients
por: Cotoia, Antonella, et al.
Publicado: (2020)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

Alterations of Circulating Bone Marrow–Derived VEGFR-2(+) Progenitor Cells in Isolated Limb Perfusion With or Without rhTNF-α
por: Nowak, Kai, et al.
Publicado: (2012)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
por: Bogoslovsky, Tanya, et al.
Publicado: (2011)

Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma
por: Wadkin, James C. R., et al.
Publicado: (2017)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Missing trial results: analysis of the current publication rate of studies in pediatric dialysis from 2003 to 2020
por: Patry, Christian, et al.
Publicado: (2022)

The CD133 and CD34 cell types in human umbilical cord blood have the capacity to produce infectious dengue virus particles
por: Vats, Amrita, et al.
Publicado: (2023)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
por: Murata, Miho, et al.
Publicado: (2012)

Effects of pitavastatin on walking capacity and CD34(+)/133(+) cell number in patients with peripheral artery disease
por: Arao, Kenshiro, et al.
Publicado: (2017)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems
por: Tsagogiorgas, Charalambos, et al.
Publicado: (2019)

Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet
por: Zheng, Shi-Min, et al.
Publicado: (2022)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Endothelial cells from cord blood CD133(+)CD34(+) progenitors share phenotypic, functional and gene expression profile similarities with lymphatics
por: Nguyen, Van Anh, et al.
Publicado: (2009)

Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury
por: Wu, Xue, et al.
Publicado: (2015)

VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination
por: Miyamoto, Yuki, et al.
Publicado: (2016)

Experimental treatment of stroke in spontaneously hypertensive rats by CD34(+ )and CD34(-) cord blood cells
por: Boltze, Johannes, et al.
Publicado: (2005)

Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133(+) and CD34(+) Hematopoietic Stem and Progenitor Cells
por: Bissels, Ute, et al.
Publicado: (2011)

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
por: Takahashi, M, et al.
Publicado: (2014)

VCAM-1 Is Upregulated in Uranium Miners Compared to Other Miners
por: Ass’ad, Nour A., et al.
Publicado: (2021)

Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration
por: Malecki, Marek, et al.
Publicado: (2013)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k7pme7gh976ikbttddog7usq1i